Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients. (Q64805584)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients. |
clinical trial |
Statements
A Randomized, Double-blind, Parallel Study Comparing Efficacy and Safety of Pegcyte (Nanogen) and Reference Product Neulastim (Roche) for Prevention of Chemotherapy (Accelerated AC Regimen)Induced Neutropenia in Breast-cancer Patients. (English)
0 references
6 October 2016
0 references
6 November 2017
0 references
128
0 references
18 year
0 references
65 year
0 references